GGrantIndex
Sort

1,049,261 grants matching t cell

Midwest Murine-Tissue Mapping Center (MM-TMC)

$2,700,000
David A Bernlohr · University Of Minnesota · U54 · FY2022 · AG

Midwest Murine-Tissue Mapping Center (MM-TMC)

$2,700,000
Paul D. Robbins · University Of Minnesota · U54 · FY2025 · AG

Genetic Modifiers of Initiation and Progression of Mammary Cancer

$2,699,964
Kent W Hunter · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Cerebral microvascular lesions and vascular and neuronal networks

$2,699,517
Brian J Bacskai · Massachusetts General Hospital · RF1 · FY2018 · NS

Genomic Database for the Yeast Saccharomyces

$2,699,376
Joe Michael Cherry · Stanford University · U41 · FY2014 · HG

Engineering T cells to Provide Durable Control of HIV-1 Replication

$2,699,182
James L Riley · University Of Pennsylvania · U19 · FY2022 · AI

Complement Mediated Remodeling in Pulmonary Vascular Disease

$2,699,112
Kurt R Stenmark · University Of Colorado Denver · P01 · FY2024 · HL

Integrative Biology Approach to Complexity of Alzheimer's Disease

$2,699,009
Eric E Schadt · Icahn School Of Medicine At Mount Sinai · U01 · FY2017 · AG

WormBase: a core data resource for C elegans and other nematodes

$2,698,766
Paul Warren Sternberg · California Institute Of Technology · P41 · FY2009 · HG

MRI: Acquisition of a Cryogenic, Aberration-Corrected Scanning Transmission Electron Microscope for Advanced Materials Research and Education

$2,698,364
Lena F Kourkoutis · Cornell University · · FY2014 · MPS

Novel Targeted Therapies for Pulmonary Fibrosis

$2,698,274
Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2016 · HL

Tissue Procurement Center (TPC) Supporting the Somatic Mosaicism across Human Tissues (SMaHT) Network

$2,698,123
Thomas J Bell · National Disease Research Interchange · U24 · FY2025 · TR

Novel Targeted Therapies for Pulmonary Fibrosis

$2,698,059
Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2017 · HL

Novel Targeted Therapies for Pulmonary Fibrosis

$2,697,831
Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2018 · HL

Computational Models of Infectious Disease Threats

$2,697,739
Donald S. Burke · University Of Pittsburgh At Pittsburgh · U54 · FY2009 · GM

Novel Targeted Therapies for Pulmonary Fibrosis

$2,697,594
Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2019 · HL

Three-Dimensional Cell and Tissue Reconstruction by Serial Block Face SEM

$2,697,483
Richard Leapman · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2021 · EB

Stem Cell-Based Therapies for Mitigation of Acute Radiation Syndromes

$2,697,066
Chandan Guha · Albert Einstein College Of Medicine · U19 · FY2013 · AI

Transcription and Replication of Oncogenic Viruses in Hypoxia

$2,696,989
Erle S Robertson · University Of Pennsylvania · P01 · FY2023 · CA

Mechanisms and biological consequences of the nuclear receptor CAR activation

$2,696,586
Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES

Silvio O. Conte Center for Stress Peptide Advanced Research, Education, & Dissemination (SPARED) at McLean Hospital

$2,696,386
William A Carlezon · Mclean Hospital · P50 · FY2022 · MH

From therapeutic mechanisms to unraveling the pathophysiology of MS

$2,696,244
Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Mucusal and Systemic Immunity, Vaccines and Microbiota Interplay in Humans

$2,696,170
Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2016 · AI

Mucusal and Systemic Immunity, Vaccines and Microbiota Interplay in Humans

$2,696,170
Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2015 · AI

Mucusal and Systemic Immunity, Vaccines and Microbiota Interplay in Humans

$2,696,170
Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2017 · AI